Core H - The purpose of the Protein Expression and Proteomics Analysis (PEP) Core is to provide state-of- the-art technology, equipment and expertise for the cloning, expression and purification of recombinant proteins required by the San Diego (SD) CFAR community, as well as the tools and expertise required for molecular analysis of proteins and protein mixtures. In particular, the PEP Core will provide protein expression and analytical tools not available to most laboratories and at a reduced cost affordable for CFAR members. The PEP Core is divided into two units based on services provided: The Protein Expression Unit (Co-Director, John Elder) will aid CFAR members as needed for cloning, expression and/or purification of proteins, based on the needs of the investigator. This unit will also maintain stocks of frequently requested viral and immunological proteins such as HIV gp120 and Gag antigens and will aid in the purification of antibodies, as required. The Proteomics Unit (Co-Director, Bruce Torbett) maintains state-of-the-art equipment and capabilities for protein analysis including nanospray mass spectrometer, HPLC, Typhoon 3-color laser for analysis of protein mixtures, light cycler instrumentation for analyzing protein mixtures, and equipment for 1- and 2-dimensional protein separations. These technologies and provided expertise will aid investigators in quantitative and qualitative analysis of their proteins and protein mixtures from cell samples. In addition, the PEP Core will provide training to CFAR members in all facets of protein expression and analysis offered by the Core, as requested by the community. Information will be provided by both one-on-one interactions, as well as through seminars on various techniques, based on the interests of the members. The long-term goal of the Core is to help facilitate efficient and economical analysis of proteins required by the CFAR membership to aid in the more rapid development of an understanding of the HIV life cycle and the development of intervention strategies against the global spread of HIV.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Center Core Grants (P30)
Project #
5P30AI036214-25
Application #
9674221
Study Section
Special Emphasis Panel (ZAI1)
Project Start
Project End
Budget Start
2019-04-01
Budget End
2020-03-31
Support Year
25
Fiscal Year
2019
Total Cost
Indirect Cost
Name
University of California, San Diego
Department
Type
DUNS #
804355790
City
La Jolla
State
CA
Country
United States
Zip Code
92093
Burlacu, Ruxandra; Umlauf, Anya; Luca, Anca et al. (2018) Sex-based differences in neurocognitive functioning in HIV-infected young adults. AIDS 32:217-225
Cachay, Edward R; Agmas, Wollelaw; Christopher Mathews, Wm (2018) Disparities in the Clinical Evolution of Anal Neoplasia in an HIV-Infected Cohort. J Racial Ethn Health Disparities 5:209-212
Pines, H A; Strathdee, S A; Hendrix, C W et al. (2018) Oral and vaginal HIV pre-exposure prophylaxis product attribute preferences among female sex workers in the Mexico-US border region. Int J STD AIDS :956462418793038
Jain, Prashant; Boso, Guney; Langer, Simon et al. (2018) Large-Scale Arrayed Analysis of Protein Degradation Reveals Cellular Targets for HIV-1 Vpu. Cell Rep 22:2493-2503
Pines, Heather A; Semple, Shirley J; Strathdee, Steffanie A et al. (2018) Vaginal washing and lubrication among female sex workers in the Mexico-US border region: implications for the development of vaginal PrEP for HIV prevention. BMC Public Health 18:1009
Sun, Alexander C; Alvarez-Fontecilla, Enrique; Venkatesh, A G et al. (2018) High-Density Redox Amplified Coulostatic Discharge-Based Biosensor Array. IEEE J Solid-State Circuits 53:2054-2064
Saag, Michael S; Benson, Constance A; Gandhi, Rajesh T et al. (2018) Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults: 2018 Recommendations of the International Antiviral Society-USA Panel. JAMA 320:379-396
Borquez, Annick; Beletsky, Leo; Nosyk, Bohdan et al. (2018) The effect of public health-oriented drug law reform on HIV incidence in people who inject drugs in Tijuana, Mexico: an epidemic modelling study. Lancet Public Health 3:e429-e437
Fraser, Hannah; Martin, Natasha K; Brummer-Korvenkontio, Henrikki et al. (2018) Model projections on the impact of HCV treatment in the prevention of HCV transmission among people who inject drugs in Europe. J Hepatol 68:402-411
Garfein, Richard S; Liu, Lin; Cuevas-Mota, Jazmine et al. (2018) Tuberculosis Treatment Monitoring by Video Directly Observed Therapy in 5 Health Districts, California, USA. Emerg Infect Dis 24:1806-1815

Showing the most recent 10 out of 921 publications